Market revenue in 2023 | USD 301.5 million |
Market revenue in 2030 | USD 407.2 million |
Growth rate | 4.4% (CAGR from 2023 to 2030) |
Largest segment | Accu-chek inform ii |
Fastest growing segment | Freestyle Lite |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Accu Check Aviva Meter, Onetouch Verio Flex, I-STAT, Freestyle Lite, Bayer CONTOUR blood glucose monitoring system, True Metrix, Accu-Chek Inform II, StatStrip |
Key market players worldwide | Roche, Abbott Laboratories, Nipro Corp, Nova Biomedical, ACON Laboratories, Bayer AG, EKF Diagnostics Holdings PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point-of-care glucose testing market will help companies and investors design strategic landscapes.
Accu-chek inform ii was the largest segment with a revenue share of 20.46% in 2023. Horizon Databook has segmented the Germany point-of-care glucose testing market based on accu check aviva meter, onetouch verio flex, i-stat, freestyle lite, bayer contour blood glucose monitoring system, true metrix, accu-chek inform ii, statstrip covering the revenue growth of each sub-segment from 2018 to 2030.
Germany offers a favorable environment for growth of POC glucose testing market and is dominating the market in Europe. This dominance can be attributed to the presence of both well-established and startup companies in the country and advanced research infrastructure as well as supportive government policies.
In addition, approximately 25% of all laboratory tests are performed in POC settings in the country. Moreover, Germany has over 600 companies with over 26,000 employees working in biotechnology sector.
Among these, around 27% of the companies are focusing on the diagnostic segment. The country has a robust healthcare infrastructure in terms of facilities and trained healthcare professionals. Thus, there are low barriers to entry for both large-scale and small-scale manufacturers, which is contributing to the revenue generation.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany point-of-care glucose testing market , including forecasts for subscribers. This country databook contains high-level insights into Germany point-of-care glucose testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account